Scancell (LON:SCLP) Stock Passes Below 200 Day Moving Average – Time to Sell?

Scancell Holdings plc (LON:SCLP) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 11.40 ($0.15) and traded as low as GBX 7.85 ($0.10). Scancell shares last traded at GBX 7.97 ($0.10), with a volume of 252,161 shares changing hands.

Scancell Price Performance

The stock has a 50-day moving average price of GBX 8.74 and a two-hundred day moving average price of GBX 11.40. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. The stock has a market cap of £82.55 million, a price-to-earnings ratio of -12.22 and a beta of 0.35.

Scancell (LON:SCLP) last issued its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. As a group, equities research analysts forecast that Scancell Holdings plc will post -2.5361112 EPS for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.